Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in VTGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$81,285
-$139,673 QoQ
Shares Held
142,607
-57.4% QoQ
Ownership
0.348%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Derivatives in VTGN

reported options exposure · as of Mar 31, 2026
CallValue
$23,028
CallShares
40,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,162,367,415 across 355 Biotechnology names. VTGN ranks #314 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VTGN

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $81,285 142,607
2026-03-31 $23,028 40,400
2025-12-31 $49,500 75,000
2025-12-31 $220,958 334,786
2025-12-31 $274,164 415,400
2025-09-30 $51,475 14,500
2025-09-30 $303,858 85,594
2025-09-30 $821,115 231,300
2025-06-30 $230,736 115,368
2025-03-31 $161,952 64,781
2024-12-31 $268,745 91,100
2024-12-31 $282,922 95,906
2024-12-31 $164,315 55,700
2024-09-30 $156,802 52,094
2024-09-30 $275,114 91,400
2024-09-30 $189,329 62,900
2024-06-30 $226,572 65,107
2024-06-30 $195,228 56,100
2024-06-30 $732,540 210,500
2024-03-31 $219,120 41,500
2024-03-31 $1,347,984 255,300
2024-03-31 $1,525,312 288,885
2023-12-31 $1,592,372 309,800
2023-12-31 $229,244 44,600
2023-09-30 $340,600 65,000
2023-09-30 $2,177,220 415,500
2023-09-30 $101,420 19,355
2023-06-30 $26,928 14,400
2023-06-30 $23,004 12,302